Physician collaborators speak out about LymphDetect at the 2026 AHNS meeting to a standing-room-only crowd Watch the Highlights

Science

How LymphDetectTM Works

LymphDetect leverages a tumor informed next generation sequencing approach to detect post-operative residual disease in lymphatic drain fluid.

Droplet leverages next-generation sequencing from Illumina and NVIDIA GPU’s and Parabricks technology to return results rapidly and efficiently.

Droplet’s novel approach
to earliest timepoint MRD

Proximity
Timing
Accuracy

Closest biofluid to tumor

Collection 24 hrs after surgery

Tumor informed bespoke assays accounting for germline mutations

Increased concentration of tumor DNA

Results available before adjuvant decisions

NGS used to detect mutations at necessary timepoint

Improved sensitivity to detect residual disease

Precision adjuvant therapy for superior outcomes

Lymphatic fluid contains 2X more tumor DNA and 65X more ctDNA than timepoint matched plasma

Proximity

Closest biofluid to tumor

Increased concentration of tumor DNA

Improved sensitivity to detect residual disease

Timing

Collection 24hrs after surgery

Results available before adjuvant decisions

Precision adjuvant therapy for superior outcomes

Accuracy

Tumor informed bespoke assays accounting for germline mutations

NGS used to detect mutations at necessary timepoint

Lymphatic fluid contains 2X more tumor DNA and 65X more ctDNA than timepoint matched plasma